Impact of template choice on homology model efficiency in virtual screening

Journal of Chemical Information and Modeling

Volumn 54, Issue 6, 2014, Pages 1661-1668

  Rataj, Krzysztof ^a   Witek, Jagna ^a   Mordalski, Stefan ^a   Kosciolek, Tomasz ^a,b   Bojarski, Andrzej J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHIC DATA; EVOLUTIONARY DISTANCE; G-PROTEIN COUPLED RECEPTORS; HOMOLOGY MODELING; SEQUENCE IDENTITY; SEROTONIN RECEPTORS; THREE-DIMENSIONAL STRUCTURE; VIRTUAL SCREENING;

PROTEINS;

G PROTEIN COUPLED RECEPTOR; LIGAND; SEROTONIN RECEPTOR;

ANIMAL; CHEMISTRY; COMPUTER PROGRAM; DRUG DESIGN; HUMAN; METABOLISM; MOLECULAR DOCKING; PROTEIN CONFORMATION; STRUCTURAL HOMOLOGY;

ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR DOCKING SIMULATION; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, SEROTONIN; SOFTWARE; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84903288876     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci500001f     Document Type: Article

References (72)

1. Wu, T. T.; Fitch, W. M.; Margoliash, E. The Information Content of Protein Amino Acid Sequences Annu. Rev. Biochem. 1974, 43, 539-566
2. Chothia, C.; Lesk, A. M. The relation between the divergence of sequence and structure in proteins EMBO J. 1986, 5, 823-826
3. Kryshtafovych, A.; Fidelis, K.; Moult, J. CASP9 results compared to those of previous CASP experiments Proteins 2011, 79 (Suppl 1) 196-207
4. Qian, B.; Raman, S.; Das, R.; Bradley, P.; McCoy, A. J.; Read, R. J.; Baker, D. High-resolution structure prediction and the crystallographic phase problem Nature 2007, 450, 259-264
5. Mariani, V.; Kiefer, F.; Schmidt, T.; Haas, J.; Schwede, T. Assessment of template based protein structure predictions in CASP9 Proteins 2011, 79 (Suppl 1) 37-58
6. Kinch, L.; Yong Shi, S.; Cong, Q.; Cheng, H.; Liao, Y.; Grishin, N. V. CASP9 assessment of free modeling target predictions Proteins 2011, 79 (Suppl 1) 59-73
7. Sandal, M.; Duy, T. P.; Cona, M.; Zung, H.; Carloni, P.; Musiani, F.; Giorgetti, A. GOMoDo: A GPCRs online modeling and docking webserver PLoS One 2013, 8 (9) e74092
8. Latek, D.; Pasznik, P.; Carlomagno, T.; Filipek, S. Towards improved quality of GPCR models by usage of multiple templates and profile-profile comparison PLoS One 2013, 8 (2) e56742
9. Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How many drug targets are there? Nat. Rev. Drug Discovery 2006, 5, 993-996
10. Xu, H. E.; Xiao, R. A new era for GPCR research: structures, biology and drug discovery Acta Pharmacol. Sin. 2012, 33, 289-290
11. Grigorieff, N.; Ceska, T. A.; Downing, K. H.; Baldwin, J. M.; Henderson, R. Electron-crystallographic refinement of the structure of bacteriorhodopsin J. Mol. Biol. 1996, 259, 393-421
12. Palczewski, K. Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor Science 2000, 289, 739-745
13. Hanson, M. A.; Roth, C. B.; Jo, E.; Griffith, M. T.; Scott, F. L.; Reinhart, G.; Desale, H.; Clemons, B.; Cahalan, S. M.; Schuerer, S. C.; Sanna, M. G.; Han, G. W.; Kuhn, P.; Rosen, H.; Stevens, R. C. Crystal structure of a lipid G protein-coupled receptor Science 2012, 335, 851-855
14. Wu, H.; Wacker, D.; Mileni, M.; Katritch, V.; Han, G. W.; Vardy, E.; Liu, W.; Thompson, A. A.; Huang, X.-P.; Carroll, F. I.; Mascarella, S. W.; Westkaemper, R. B.; Mosier, P. D.; Roth, B. L.; Cherezov, V.; Stevens, R. C. Structure of the human κ-opioid receptor in complex with JDTic Nature 2012, 485, 327-332
15. Thompson, A. A.; Liu, W.; Chun, E.; Katritch, V.; Wu, H.; Vardy, E.; Huang, X.-P.; Trapella, C.; Guerrini, R.; Calo, G.; Roth, B. L.; Cherezov, V.; Stevens, R. C. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic Nature 2012, 485, 395-399
16. Zhang, C.; Srinivasan, Y.; Arlow, D. H.; Fung, J. J.; Palmer, D.; Zheng, Y.; Green, H. F.; Pandey, A.; Dror, R. O.; Shaw, D. E.; Weis, W. I.; Coughlin, S. R.; Kobilka, B. K. High-resolution crystal structure of human protease-activated receptor 1 Nature 2012, 492, 387-392
17. Kruse, A. C.; Hu, J.; Pan, A. C.; Arlow, D. H.; Rosenbaum, D. M.; Rosemond, E.; Green, H. F.; Liu, T.; Chae, P. S.; Dror, R. O.; Shaw, D. E.; Weis, W. I.; Wess, J.; Kobilka, B. K. Structure and dynamics of the M3 muscarinic acetylcholine receptor Nature 2012, 482, 552-556
18. Haga, K.; Kruse, A. C.; Asada, H.; Yurugi-Kobayashi, T.; Shiroishi, M.; Zhang, C.; Weis, W. I.; Okada, T.; Kobilka, B. K.; Haga, T.; Kobayashi, T. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist Nature 2012, 482, 547-551
19. Wacker, D.; Wang, C.; Katritch, V.; Han, G. W.; Huang, X.-P.; Vardy, E.; McCorvy, J. D.; Jiang, Y.; Chu, M.; Siu, F. Y.; Liu, W.; Xu, H. E.; Cherezov, V.; Roth, B. L.; Stevens, R. C. Structural Features for Functional Selectivity at Serotonin Receptors Science 2013, 340, 615-619
20. Wang, C.; Jiang, Y.; Ma, J.; Wu, H.; Wacker, D.; Katritch, V.; Han, G. W.; Liu, W.; Huang, X.-P.; Vardy, E.; McCorvy, J. D.; Gao, X.; Zhou, E. X.; Melcher, K.; Zhang, C.; Bai, F.; Yang, H.; Yang, L.; Jiang, H.; Roth, B. L.; Cherezov, V.; Stevens, R. C.; Xu, H. E. Structural Basis for Molecular Recognition at Serotonin Receptors Science 2013, 340, 610-614
21. Cherezov, V.; Rosenbaum, D. M.; Hanson, M. a; Rasmussen, S. G. F.; Thian, F. S.; Kobilka, T. S.; Choi, H.-J.; Kuhn, P.; Weis, W. I.; Kobilka, B. K.; Stevens, R. C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 2007, 318, 1258-1265
22. Jaakola, V.-P.; Griffith, M. T.; Hanson, M. A.; Cherezov, V.; Chien, E. Y. T.; Lane, J. R.; Ijzerman, A. P.; Stevens, R. C. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Science 2008, 322, 1211-1217
23. Chien, E. Y. T.; Liu, W.; Zhao, Q.; Katritch, V.; Han, G. W.; Hanson, M. a; Shi, L.; Newman, A. H.; Javitch, J. a; Cherezov, V.; Stevens, R. C. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 2010, 330, 1091-1095
24. Wu, B.; Chien, E. Y. T.; Mol, C. D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F. C.; Hamel, D. J.; Kuhn, P.; Handel, T. M.; Cherezov, V.; Stevens, R. C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 2010, 330, 1066-1071
25. Shimamura, T.; Shiroishi, M.; Weyand, S.; Tsujimoto, H.; Winter, G.; Katritch, V.; Abagyan, R.; Cherezov, V.; Liu, W.; Han, G. W.; Kobayashi, T.; Stevens, R. C.; Iwata, S. Structure of the human histamine H1 receptor complex with doxepin Nature 2011, 475, 65-70
26. Park, S. H.; Das, B. B.; Casagrande, F.; Tian, Y.; Nothnagel, H. J.; Chu, M.; Kiefer, H.; Maier, K.; De Angelis, A. A.; Marassi, F. M.; Opella, S. J. Structure of the chemokine receptor CXCR1 in phospholipid bilayers Nature 2012, 491, 779-783
27. Kennett, G. A.; Dourish, C. T.; Curzon, G. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression Eur. J. Pharmacol. 1987, 134, 265-274
28. Sato, K.; Yoshida, K.; Takahashi, H.; Ito, K.; Kamata, M.; Higuchi, H.; Shimizu, T.; Itoh, K.; Inoue, K.; Tezuka, T.; Suzuki, T.; Ohkubo, T.; Sugawara, K.; Otani, K. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder Neuropsychobiology 2002, 48, 136-140
29. Schechter, L. E.; Lin, Q.; Smith, D. L.; Zhang, G.; Shan, Q.; Platt, B.; Brandt, M. R.; Dawson, L. A.; Cole, D.; Bernotas, R.; Robichaud, A.; Rosenzweig-Lipson, S.; Beyer, C. E. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466 Neuropsychopharmacology 2008, 33, 1323-1335
30. Hedlund, P. B.; Sutcliffe, J. G. Functional, molecular and pharmacological advances in 5-HT7 receptor research Trends Pharmacol. Sci. 2004, 25, 481-486
31. Ruat, M.; Traiffort, E.; Arrang, J. M.; Tardivel-Lacombe, J.; Diaz, J.; Leurs, R.; Schwartz, J. C. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation Biochem. Biophys. Res. Commun. 1993, 193, 268-276
32. Kohen, R.; Metcalf, M. A.; Khan, N.; Druck, T.; Huebner, K.; Lachowicz, J. E.; Meltzer, H. Y.; Sibley, D. R.; Roth, B. L.; Hamblin, M. W. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor J. Neurochem. 1996, 66, 47-56
33. Perez-García, G.; Meneses, A. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task Pharmacol., Biochem. Behav. 2005, 81, 673-682
34. King, M. V.; Marsden, C.; Fone, K. C. A role for the 5-HT(1A), 5-HT(4) and 5-HT(6) receptors in learning and memory Trends Pharmacol. Sci. 2008, 29, 482-92
35. Barnes, N. M.; Sharp, T. A review of central 5-HT receptors and their function Neuropharmacology 1999, 38, 1083-1152
36. Gaddum, J. H.; Picarelli, Z. P. Two kinds of tryptamine receptor Br. J. Pharmacol. 1957, 12, 323-328
37. De Almeida, J.; Mengod, G. J. Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment Neurochemistry 2008, 107, 488-496
38. Van de Kar, L. D.; Javed, A.; Zhang, Y.; Serres, F.; Raap, D. K.; Gray, T. S. J. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells Neuroscience 2001, 21, 3572-3579
39. Feniuk, W.; Humphrey, P. P.; Watts, A. D. 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle Eur. J. Pharmacol. 1983, 96, 71-78
40. Bard, J. A.; Zgombick, J.; Adham, N.; Vaysse, P.; Branchek, T. A.; Weinshank, R. L. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase J. Biol. Chem. 1993, 268, 23422-23426
41. Homan, E. J.; Wikström, H. V.; Grol, C. J. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT Bioorg. Med. Chem. 1999, 7, 1805-1820
42. Hirst, W. D.; Abrahamsen, B.; Blaney, F. E.; Calver, A. R.; Aloj, L.; Price, G. W.; Medhurst, A. D. Differences in the Central Nervous System Distribution and Pharmacology of the Mouse 5-Hydroxytryptamine-6 Receptor Compared with Rat and Human Receptors Investigated by Radioligand Binding, Site-Directed Mutagenesis, and Molecular Modeling Mol. Pharmacol. 2003, 64, 1295-1308
43. Lepailleur, A.; Bureau, R.; Paillet-Loilier, M.; Fabis, F.; Saettel, N.; Lemaître, S.; Dauphin, F.; Lesnard, A.; Lancelot, J.-C.; Rault, S. Molecular modeling studies focused on 5-HT7 versus 5-HT1A selectivity. Discovery of novel phenylpyrrole derivatives with high affinity for 5-HT7 receptors J. Chem. Inf. Model. 2005, 45, 1075-1081
44. Nowak, M.; Kołaczkowski, M.; Pawłowski, M.; Bojarski, A. J. Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry J. Med. Chem. 2006, 49, 205-214
45. Mosier, P. D.; Kolanos, R.; Roth, B. L.; Glennon, R. A. Binding of Serotonin and N 1 -Benzenesulfonyltryptamine-Related Analogs at Human 5-HT 6 Serotonin Receptors: Receptor Modeling Studies J. Med. Chem. 2008, 51, 603-611
46. Pecic, S.; Makkar, P.; Chaudhary, S.; Reddy, B. V.; Navarro, H. A.; Harding, W. W. Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies Bioorg. Med. Chem. 2010, 18, 5562-5575
47. Badarau, E.; Bugno, R.; Suzenet, F.; Bojarski, A. J.; Finaru, A.-L.; Guillaumet, G. SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling Bioorg. Med. Chem. 2010, 18, 1958-1967
48. De la Fuente, T.; Martín-Fontecha, M.; Sallander, J.; Benhamú, B.; Campillo, M.; Medina, R. a; Pellissier, L. P.; Claeysen, S.; Dumuis, A.; Pardo, L.; López-Rodríguez, M. L. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation J. Med. Chem. 2010, 53, 1357-1369
49. Hao, M.; Li, Y.; Li, H.; Zhang, S. Investigation of the Structure Requirement for 5-HT(6) Binding Affinity of Arylsulfonyl Derivatives: A Computational Study Int. J. Mol. Sci. 2011, 12, 5011-5030
50. van Loevezijn, A.; Venhorst, J.; Wouter, I.; Bakker, I.; de Korte, C.; de Looff, W.; Verhoog, S.; van Wees, J.; van Hoeve, M.; van de Woestijne, R.; van der Neut, M. A. W.; Borst, A. J. M.; van Dongen, M. J. P.; Kruse, C. G. N0 -(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT6R) Antagonists with Unique Structural Features J. Med. Chem. 2011, 54, 7030-7054
51. Yap, B. K.; Buckle, M. J. C.; Doughty, S. W. Homology modeling of the human 5-HT(1A), 5-HT (2A), D1, and D2 receptors: model refinement with molecularaz dynamics simulations and docking evaluation J. Mol. Model. 2012, 18, 3639-3655
52. Warne, T.; Serrano-Vega, M. J.; Baker, J. G.; Moukhametzianov, R.; Edwards, P. C.; Henderson, R.; Leslie, A. G. W.; Tate, C. G.; Schertler, G. F. X. Structure of a beta1-adrenergic G-protein-coupled receptor Nature 2008, 454, 486-491
53. Discovery Studio Modeling Environment, Release 3.5; Accelrys Software Inc.: San Diego, CA, 2012.
54. Ballesteros, J.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors Methods Neurosci. 1995, 25, 366-428
55. Harris, R. N.; Stabler, R. S.; Repke, D. B.; Kress, J. M.; Walker, K. A.; Martin, R. S.; Brothers, J. M.; Ilnicka, M.; Lee, S. W.; Mirzadegan, T. Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism Bioorg. Med. Chem. Lett. 2010, 20, 3436-3440
56. Purohit, A.; Herrick-Davis, K.; Teitler, M. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor Synapse 2003, 47, 218-224
57. Amico, M.; Finelli, M.; Rossi, I.; Zauli, A.; Elofsson, A.; Viklund, H.; von Heijne, G.; Jones, D.; Krogh, A.; Fariselli, P.; P. L, M.; Casadio, R. PONGO: a web server for multiple predictions of all-alpha transmembrane proteins Nucleic Acids Res. 2006, 34, 169-172
58. Jones, D. Protein secondary structure prediction based on position-specific scoring matrices J. Mol. Biol. 1999, 292, 195-202
59. Buchan, D. W. A.; Minneci, F.; Nugent, T. C. O.; Bryson, K.; Jones, D. T. Scalable web services for the PSIPRED Protein Analysis Workbench Nucleic Acids Res. 2013, 349-357
60. Sigrist, C. J. A.; Cerutti, L.; Hulo, N.; Gattiker, A.; Falquet, L.; Pagni, M.; Bairoch, A. PROSITE: a documented database using patterns and profiles as motif descriptors Br. Bioinform. 2002, 3, 265-274
61. Néron, B.; Ménager, H.; Maufrais, C.; Joly, N.; Maupetit, J.; Letort, S.; Carrere, S.; Tuffery, P.; Letondal, C. Mobyle: a new full web bioinformatics framework Bioinformatics 2009, 25, 3005-3011
62. Šali, A.; Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints J. Mol. Biol. 1993, 234, 779-815
63. Glide, version 5.7; Schrödinger, LLC: New York, 2011.
64. ChEMBL-11, ChEMBL-EBI. http://www.ebi.ac.uk/chembldb/index.php (accessed September 1, 2011).
65. LigPrep, version 2.5; Schrödinger, LLC: New York, 2011.
66. Canvas, version 1.4; Schrödinger, LLC: New York, 2011.
67. Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: A Free Tool to Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52, 1757-1768
68. SiteMap, version 2.6; Schrödinger, LLC: New York, 2012.
69. Beuming, T.; Sherman, W. Current Assessment of Docking into GPCR Crystal Structures and Homology Models: Successes, Challenges, and Guidelines J. Chem. Inf. Model. 201, 52, 3263-3277
70. López-Rodríguez, M. L.; Benhamú, B.; de la Fuente, T.; Sanz, A.; Pardo, L.; Campillo, M. A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists J. Med. Chem. 2005, 48, 4216-4219
71. Granier, S. Structure of mu and delta opioid receptors Med. Sci. (Paris) 2012, 28, 870-875
72. Kufareva, I.; Rueda, M.; Katritch, V.; Stevens, R. C. Article Status of GPCR Modeling and Docking as Reflected by Community-wide GPCR Dock 2010 Assessment Structure 2011, 19, 1108-1126